NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Australia flag Australia · Delayed Price · Currency is AUD
0.0540
+0.0010 (1.89%)
May 14, 2025, 11:15 AM AEST
20.00%
Market Cap 7.66M
Revenue (ttm) 2.21M
Net Income (ttm) 1.19M
Shares Out 144.60M
EPS (ttm) 0.01
PE Ratio 6.54
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,491
Average Volume 1,305,391
Open 0.0540
Previous Close 0.0530
Day's Range 0.0540 - 0.0540
52-Week Range 0.0330 - 0.0690
Beta 1.23
RSI 65.19
Earnings Date May 27, 2025

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of novel peptide-based pharmaceutical products. The company is involved in the development of therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative Alzheimer’s disease, multiple scierosis, glaucoma, optic nerve atrophy, and other diseases. The company was incorporated in 2002 and is based in Perth, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol NSB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.